Takeda Pharmaceutical Co. agreed to sell its Japanese consumer health care business for ¥242 billion ($2.3 billion) to Blackstone Group Inc., which plans to take the over-the-counter medication unit public in about five years. For the drugmaker, the sale could represent one of the last ...
Takeda on track to sell OTC drug unit to Blackstone for ¥300 billion
Takeda is aiming to reduce debts after its purchase of Irish drugmaker Shire in January last year, the largest-ever Japanese acquisition of a foreign company.
Forecasting rebound, Blackstone weighs investment in Japan tourism
Major U.S. investment firm Blackstone Group Inc. will consider investing in tourism-linked companies in Japan, expecting inbound travel demand to recover after the coronavirus crisis, sources said Monday. Blackstone forecasts that demand erased by the COVID-19 pandemic may return to some extent in the next ...
GE said to be in talks with Blackstone, Mitsubishi on sale of assets
General Electric Co. is discussing the sale of parts of its finance business, including the $74 billion U.S. commercial-lending unit, with potential buyers including Blackstone Group LP, Mitsubishi UFJ Financial Group Inc. and Wells Fargo & Co., said people with knowledge of the matter. Also ...
